Selected research
Industry Growth & Trends
Global Modafinil Oral Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Modafinil Oral Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Modafinil Oral Drugs include Xiangbei Welman Pharmaceutical, Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Modafinil Oral Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Modafinil Oral Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Modafinil Oral Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Modafinil Oral Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Modafinil Oral Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Modafinil Oral Drugs Market by Company
Xiangbei Welman Pharmaceutical
Zydus
Watson Labs
Sun Pharmaceutical
Orbion Pharmaceuticals
Cephalon
Aurobindo Pharma
Apotex
Alembic Pharma
Modafinil Oral Drugs Segment by Type
Tablets
Capsules
Modafinil Oral Drugs Segment by Application
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Narcolepsy
Other
Modafinil Oral Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Oral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Modafinil Oral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Oral Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Modafinil Oral Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Modafinil Oral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Obstructive Sleep Apnea
- Shift Work Sleep Disorder
- Narcolepsy
- Other
Companies covered
- Xiangbei Welman Pharmaceutical
- Zydus
- Watson Labs
- Sun Pharmaceutical
- Orbion Pharmaceuticals
- Cephalon
- Aurobindo Pharma
- Apotex
- Alembic Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Modafinil Oral Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Modafinil Oral Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Modafinil Oral Drugs Market by Type
- 1.3.1 Tablets
- 1.3.2 Capsules
- 1.4 Global Modafinil Oral Drugs Market Size by Type
- 1.4.1 Global Modafinil Oral Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Modafinil Oral Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Modafinil Oral Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Modafinil Oral Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Modafinil Oral Drugs Industry Trends
- 2.2 Modafinil Oral Drugs Industry Drivers
- 2.3 Modafinil Oral Drugs Industry Opportunities and Challenges
- 2.4 Modafinil Oral Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Modafinil Oral Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Modafinil Oral Drugs Sales (2021-2026)
- 3.3 Global Top Players by Modafinil Oral Drugs Price (2021-2026)
- 3.4 Global Modafinil Oral Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Modafinil Oral Drugs Major Company Production Sites & Headquarters
- 3.6 Global Modafinil Oral Drugs Company, Product Type & Application
- 3.7 Global Modafinil Oral Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Modafinil Oral Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Modafinil Oral Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Modafinil Oral Drugs Tier 1, Tier 2, and Tier 3
4 Modafinil Oral Drugs Regional Status and Outlook
- 4.1 Global Modafinil Oral Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Modafinil Oral Drugs Historic Market Size by Region
- 4.2.1 Global Modafinil Oral Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Modafinil Oral Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Modafinil Oral Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Modafinil Oral Drugs Forecasted Market Size by Region
- 4.3.1 Global Modafinil Oral Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Modafinil Oral Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Modafinil Oral Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Modafinil Oral Drugs by Application
- 5.1 Modafinil Oral Drugs Market by Application
- 5.1.1 Obstructive Sleep Apnea
- 5.1.2 Shift Work Sleep Disorder
- 5.1.3 Narcolepsy
- 5.1.4 Other
- 5.2 Global Modafinil Oral Drugs Market Size by Application
- 5.2.1 Global Modafinil Oral Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Modafinil Oral Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Modafinil Oral Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Modafinil Oral Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Xiangbei Welman Pharmaceutical
- 6.1.1 Xiangbei Welman Pharmaceutical Company Information
- 6.1.2 Xiangbei Welman Pharmaceutical Business Overview
- 6.1.3 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio
- 6.1.5 Xiangbei Welman Pharmaceutical Recent Developments
- 6.2 Zydus
- 6.2.1 Zydus Company Information
- 6.2.2 Zydus Business Overview
- 6.2.3 Zydus Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Zydus Modafinil Oral Drugs Product Portfolio
- 6.2.5 Zydus Recent Developments
- 6.3 Watson Labs
- 6.3.1 Watson Labs Company Information
- 6.3.2 Watson Labs Business Overview
- 6.3.3 Watson Labs Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Watson Labs Modafinil Oral Drugs Product Portfolio
- 6.3.5 Watson Labs Recent Developments
- 6.4 Sun Pharmaceutical
- 6.4.1 Sun Pharmaceutical Company Information
- 6.4.2 Sun Pharmaceutical Business Overview
- 6.4.3 Sun Pharmaceutical Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio
- 6.4.5 Sun Pharmaceutical Recent Developments
- 6.5 Orbion Pharmaceuticals
- 6.5.1 Orbion Pharmaceuticals Company Information
- 6.5.2 Orbion Pharmaceuticals Business Overview
- 6.5.3 Orbion Pharmaceuticals Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio
- 6.5.5 Orbion Pharmaceuticals Recent Developments
- 6.6 Cephalon
- 6.6.1 Cephalon Company Information
- 6.6.2 Cephalon Business Overview
- 6.6.3 Cephalon Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Cephalon Modafinil Oral Drugs Product Portfolio
- 6.6.5 Cephalon Recent Developments
- 6.7 Aurobindo Pharma
- 6.7.1 Aurobindo Pharma Company Information
- 6.7.2 Aurobindo Pharma Business Overview
- 6.7.3 Aurobindo Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Aurobindo Pharma Modafinil Oral Drugs Product Portfolio
- 6.7.5 Aurobindo Pharma Recent Developments
- 6.8 Apotex
- 6.8.1 Apotex Company Information
- 6.8.2 Apotex Business Overview
- 6.8.3 Apotex Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Apotex Modafinil Oral Drugs Product Portfolio
- 6.8.5 Apotex Recent Developments
- 6.9 Alembic Pharma
- 6.9.1 Alembic Pharma Company Information
- 6.9.2 Alembic Pharma Business Overview
- 6.9.3 Alembic Pharma Modafinil Oral Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Alembic Pharma Modafinil Oral Drugs Product Portfolio
- 6.9.5 Alembic Pharma Recent Developments
7 North America by Country
- 7.1 North America Modafinil Oral Drugs Sales by Country
- 7.1.1 North America Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Modafinil Oral Drugs Sales by Country (2021-2026)
- 7.1.3 North America Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Modafinil Oral Drugs Market Size by Country
- 7.2.1 North America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Modafinil Oral Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Modafinil Oral Drugs Sales by Country
- 8.1.1 Europe Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Modafinil Oral Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Modafinil Oral Drugs Market Size by Country
- 8.2.1 Europe Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Modafinil Oral Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Modafinil Oral Drugs Sales by Country
- 9.1.1 Asia-Pacific Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Modafinil Oral Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Modafinil Oral Drugs Market Size by Country
- 9.2.1 Asia-Pacific Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Modafinil Oral Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Modafinil Oral Drugs Sales by Country
- 10.1.1 South America Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Modafinil Oral Drugs Sales by Country (2021-2026)
- 10.1.3 South America Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Modafinil Oral Drugs Market Size by Country
- 10.2.1 South America Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Modafinil Oral Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Modafinil Oral Drugs Sales by Country
- 11.1.1 Middle East and Africa Modafinil Oral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Modafinil Oral Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Modafinil Oral Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Modafinil Oral Drugs Market Size by Country
- 11.2.1 Middle East and Africa Modafinil Oral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Modafinil Oral Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Modafinil Oral Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Modafinil Oral Drugs Value Chain Analysis
- 12.1.1 Modafinil Oral Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Modafinil Oral Drugs Production Mode & Process
- 12.2 Modafinil Oral Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Modafinil Oral Drugs Distributors
- 12.2.3 Modafinil Oral Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst